Teva signs $4bn M&A loan at mates rates
Israeli drugmaker Teva Pharmaceutical Industries has signed loans totalling $4bn to part-fund its $6.8bn takeover of US pharmaceutical credit Cephalon.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ European securitization issuance database
- ✔ Daily newsletters across markets and asset classes
- ✔ 1 weekly securitization podcast
